Suppression of CYLD by HER3 confers ovarian cancer platinum resistance via inhibiting apoptosis and by inducing drug efflux.
Saved in:
| Title: | Suppression of CYLD by HER3 confers ovarian cancer platinum resistance via inhibiting apoptosis and by inducing drug efflux. |
|---|---|
| Authors: | Zhang, Ye1 (AUTHOR), Qiu, Jian-Ge1,2 (AUTHOR), Wang, Wei2 (AUTHOR), Sun, Fan-Li2 (AUTHOR), Wang, Xue2 (AUTHOR), Liu, Wen-Jing3 (AUTHOR), Jia, Xiao-Yu2 (AUTHOR), Ji, Hongbin4 (AUTHOR), Wang, Lin1,2 (AUTHOR) wanglinzz@zzu.edu.cn, Jiang, Bing-Hua1 (AUTHOR) binghjiang@zzu.edu.cn |
| Source: | Experimental Hematology & Oncology. 2/26/2025, Vol. 14 Issue 1, p1-20. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 183285097 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Suppression of CYLD by HER3 confers ovarian cancer platinum resistance via inhibiting apoptosis and by inducing drug efflux. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Zhang%2C+Ye%22">Zhang, Ye</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qiu%2C+Jian-Ge%22">Qiu, Jian-Ge</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Wei%22">Wang, Wei</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sun%2C+Fan-Li%22">Sun, Fan-Li</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Xue%22">Wang, Xue</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Wen-Jing%22">Liu, Wen-Jing</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jia%2C+Xiao-Yu%22">Jia, Xiao-Yu</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ji%2C+Hongbin%22">Ji, Hongbin</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Lin%22">Wang, Lin</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> wanglinzz@zzu.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Jiang%2C+Bing-Hua%22">Jiang, Bing-Hua</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> binghjiang@zzu.edu.cn</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Experimental+Hematology+%26+Oncology%22">Experimental Hematology & Oncology</searchLink>. 2/26/2025, Vol. 14 Issue 1, p1-20. 20p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=183285097 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s40164-025-00620-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 20 StartPage: 1 Titles: – TitleFull: Suppression of CYLD by HER3 confers ovarian cancer platinum resistance via inhibiting apoptosis and by inducing drug efflux. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhang, Ye – PersonEntity: Name: NameFull: Qiu, Jian-Ge – PersonEntity: Name: NameFull: Wang, Wei – PersonEntity: Name: NameFull: Sun, Fan-Li – PersonEntity: Name: NameFull: Wang, Xue – PersonEntity: Name: NameFull: Liu, Wen-Jing – PersonEntity: Name: NameFull: Jia, Xiao-Yu – PersonEntity: Name: NameFull: Ji, Hongbin – PersonEntity: Name: NameFull: Wang, Lin – PersonEntity: Name: NameFull: Jiang, Bing-Hua IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 02 Text: 2/26/2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 21623619 Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: Experimental Hematology & Oncology Type: main |
| ResultId | 1 |